Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

793 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Opioid use disorder: current trends and potential treatments.
Lee YK, Gold MS, Blum K, Thanos PK, Hanna C, Fuehrlein BS. Lee YK, et al. Among authors: gold ms. Front Public Health. 2024 Jan 25;11:1274719. doi: 10.3389/fpubh.2023.1274719. eCollection 2023. Front Public Health. 2024. PMID: 38332941 Free PMC article. Review.
Dopamine Dysregulation in Reward and Autism Spectrum Disorder.
Blum K, Bowirrat A, Sunder K, Thanos PK, Hanna C, Gold MS, Dennen CA, Elman I, Murphy KT, Makale MT. Blum K, et al. Among authors: gold ms. Brain Sci. 2024 Jul 22;14(7):733. doi: 10.3390/brainsci14070733. Brain Sci. 2024. PMID: 39061473 Free PMC article. Review.
Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration Therapy.
Zeine F, Jafari N, Baron D, Bowirrat A, Pinhasov A, Norling B, Martinez KC, Nami M, Manavi N, Sunder K, Rabin DM, Bagchi D, Khalsa J, Gold MS, Sipple D, Barzegar M, Bodhanapati J, Khader W, Carney P, Dennen CA, Gupta A, Elman I, Badgaiyan RD, Modestino EJ, Thanos PK, Hanna C, McLaughlin T, Cadet JL, Soni D, Braverman ER, Barh D, Giordano J, Edwards D, Ashford JW, Gondre-Lewis MC, Gilley E, Murphy KT, Lewandrowski KU, Sharafshah A, Makale M, Fuehrlein B, Blum K. Zeine F, et al. Among authors: gold ms. J Addict Psychiatry. 2024;8(1):50-95. Epub 2024 Jun 20. J Addict Psychiatry. 2024. PMID: 39635461 Free PMC article.
Psychedelic drugs for psychiatric disorders.
da Costa SC, Oesterle T, Rummans TA, Richelson E, Gold M. da Costa SC, et al. J Neurol Sci. 2022 Sep 15;440:120332. doi: 10.1016/j.jns.2022.120332. Epub 2022 Jul 5. J Neurol Sci. 2022. PMID: 35841696 Review.
Dopaminergic dysfunction: Role for genetic & epigenetic testing in the new psychiatry.
Blum K, Ashford JW, Kateb B, Sipple D, Braverman E, Dennen CA, Baron D, Badgaiyan R, Elman I, Cadet JL, Thanos PK, Hanna C, Bowirrat A, Modestino EJ, Yamamoto V, Gupta A, McLaughlin T, Makale M, Gold MS. Blum K, et al. Among authors: gold ms. J Neurol Sci. 2023 Oct 15;453:120809. doi: 10.1016/j.jns.2023.120809. Epub 2023 Sep 23. J Neurol Sci. 2023. PMID: 37774561
A historical perspective on clonidine as an alpha-2A receptor agonist in the treatment of addictive behaviors: Focus on opioid dependence.
Gold MS, Blum K, Bowirrat A, Pinhasov A, Bagchi D, Dennen CA, Thanos PK, Hanna C, Lewandrowski KU, Sharafshah A, Elman I, Badgaiyan RD. Gold MS, et al. INNOSC Theranostics Pharmacol Sci. 2024;7(3):1918. doi: 10.36922/itps.1918. Epub 2024 Jul 29. INNOSC Theranostics Pharmacol Sci. 2024. PMID: 39119149 Free PMC article.
793 results